Public signalCompany raiseAuto-indexed · Unverified

GNT Pharmaceuticals, Inc. is raising up to $150K

GNT Pharmaceuticals, Inc.· LOUISVILLE, US· Pharmaceuticals· Filed Mar 3, 2025

GNT Pharmaceuticals, Inc. has announced an offering and is seeking capital. No amount is confirmed as raised. Based in LOUISVILLE, KENTUCKY, US. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Seeking up to
$150,000
Target — nothing confirmed as raised
Confidence60%
Seeking up to
$150,000
Investors
0
Incorporated
2024
Jurisdiction
DELAWARE

On the record

Location
LOUISVILLE, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Announced target
Target amount
$150,000
Filing date
Mar 3, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2024
Industry group
Pharmaceuticals
Number of investors
0
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$150,000
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Reg D offering of up to 150,000 USD filed; nothing reported sold yet.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Mar 3, 2025. Details beyond the filing have not been verified.

Tags

USCompanyPharmaceuticalsCompany Raise

Are you associated with GNT Pharmaceuticals, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record